Angiotensin II generation at the cell surface of activated neutrophils: Novel cathepsin G-mediated catalytic activity that is resistant to inhibition

Journal of Immunology

Volumn 160, Issue 3, 1998, Pages 1436-1443

  Owen, Caroline A ^a   Campbell, Edward J ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ANGIOTENSIN; ANGIOTENSIN I; ANGIOTENSINOGEN; CATHEPSIN G; PROTEINASE INHIBITOR;

ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL PERMEABILITY; CELL SURFACE; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME MECHANISM; FLUID BALANCE; HUMAN; HUMAN CELL; INFLAMMATION; NEUTROPHIL; PRIORITY JOURNAL;

ALPHA 1-ANTICHYMOTRYPSIN; ANGIOTENSIN I; ANGIOTENSIN II; CATALYSIS; CATHEPSINS; CELL MEMBRANE; ENZYME ACTIVATION; HUMANS; KINETICS; LEUKOCYTE ELASTASE; MYELOBLASTIN; NEUTROPHIL ACTIVATION; NEUTROPHILS; PEPTIDYL-DIPEPTIDASE A; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS;

EID: 0031939933     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Peach, M. J. 1977. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol. Rev. 57:313.
2. Gimbrone, M. A., Jr. and R. W. Alexander. 1975. Angiotensin II stimulation of prostaglandin production in cultured human vascular endothelium. Science 189:219.
3. Robertson, A. L., and P. A. Khairallah. 1974. Effects of angiotensin II on the permeability of the vascular wall. In Angiotensin. I. H. Page and F. M. Bumpus, eds. Springer-Verlag, New York, p. 500.
4. Simon, M. R., D. E. Engel, J. V. Weinstock, and L. D. Roi. 1985. The effect of angiotensin II on human mononuclear cell reactivity: suppression of PHA-P-induced thymidine incorporation. Immunol. Invest. 14:389.
5. Goetzl, E. J., L. B. Klickstein, K. W. K. Watt, and B. U. Wintroub. 1980. The preferential human mononuclear leukocyte chemotactic activity of the substituent tetrapeptides of angiotensin II. Biochem. Biophys. Res. Commun. 97:1097.
6. Farber, H. W., D. M. Center, S. Rounds, and S. M. Danilov. 1990. Components of the angiotensin system cause release of a neutrophil chemoattractant from cultured bovine and human endothelial cells. Eur. Heart J. 11:100.
7. Weinstock, J. V., A. M. Blum, and J. T. Kassab. 1987. Angiotensin II is chemotactic for a T-cell subset which can express migration inhibition factor activity in murine Schistosomiasis mansoni. Cell. Immunol. 107:180.
8. Weinstock, J. V., and J. Kassab. 1986. Chemotactic response of splenic mononuclear cells to angiotensin II in murine shistosomiasis. J. Immunol. 137:2020.
9. Farber, H. W., D. M. Center, and S. Rounds. 1985. Bovine and human endothelial cell production of neutrophil chemoattractant activity in response to components of the angiotensin system. Circ. Res. 57:898.
10. Goetzl, E. J., L. B. Klickstein, K. W. Watt, and B. U. Wintoub. 1980. The preferential human mononuclear leukocyte chemotactic activity of the substituent tetrapeptides of angiotensin II. Biochem. Biophys. Res. Commun. 97:1097.
11. Caldwell, P. R. B., B. C. Seegal, K. C. Hsu, M. Das, and R. L. Soffer. 1976. Angiotensin-converting enzyme: vascular endothelial localization. Science 191:1050.
12. Urata, H., H. Nishimura, and D. Ganten. 1996. Chymase-dependent angiotensin II formin system in humans. Am. J. Hypertension 9:277.
13. Liao, Y., and A. Husain. 1995. The chymase-angiotensin system in humans: Biochemistry, molecular biology and potential role in cardiovascular diseases. Can. J. Cardiol. 11(Suppl. F):13F.
14. Urata, H., A. Kinoshita, F. M. Bumpus, and A. Husain. 1990. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J. Biol. Chem. 265:22348.
15. Urata, H., S. Hoffmann, and D. Ganten. 1994. Tissue angiotensin II system in the human heart. Eur. Heart J. 15(Suppl. D):68.
16. Owen, C. A., M. A. Campbell, S. S. Boukedes, R. A. Stockley, and E. J. Campbell. 1994. A discrete subpopulation of human monocytes expresses a neutrophil-like pro-inflammatory (P) phenotype Am. J. Physiol. 267:L775.
17. Senior, R. M., and E. J. Campbell. 1984. Cathepsin G in human mononuclear phagocytes: comparisons between monocytes and U937 monocyte-like cells. J. Immunol. 132:2547.
18. Campbell, E. J., E. K. Silverman, and M. A. Campbell. 1989. Elastase and cathepsin G of human monocytes: quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity. J. Immunol. 143:2961.
19. Kargi, H. A., E. J. Campbell, and C. Kuhn III. 1990. Elastase and cathepsin G of human monocytes: heterogeneity and subcellular localization to peroxidase-positive granules. J. Histochem. Cytochem. 38:1179.
20. Wintroub, B. U., L. B. Klickstein, and K. W. K. Watt. 1981. A human neutrophil-dependent pathway for generation of angiotensin II: purification of the product and identification as angiotensin II. J. Clin. Invest. 68:484.
21. Reilly, C. F., D. A. Tewksbury, N. M. Schlechter, and J. Travis. 1982. Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J. Biol. Chem. 257:8619.
22. Klickstein, L. B., C. E. Kaempfer, and B. U. Wintroub. 1982. The granulocyte angiotensin system. J. Biol. Chem. 257:15042.
23. Twumasi, D. Y., and I. E. Liener. 1977. Proteases from purulent sputum: purification and properties of the elastase and chymotrypsin-like enzymes. J. Biol. Chem. 252:1917.
24. Schmidt, W. 1978. Differential release of elastase and chymotrypsin from polymorphonuclear leukocytes. In Neutral Proteases of Polymorphonuclear Leukocytes. K. Havemann and A. Janoff, eds. Urban & Schwarzenberg, Baltimore, p. 77.
25. Owen, C. A., M. A. Campbell, S. S. Boukedes, and E. J. Campbell. 1995. Inducible binding of cathepsin G to the cell surface of neutrophils: a mechanism for mediating extracellular proteolytic activity of cathepsin G. J. Immunol. 155:5803.
26. Owen, C. A., M. A. Campbell, P. L. Sannes, S. S. Boukedes, and E. J. Campbell. 1995. Cell-surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J. Cell Biol. 131:775.
27. Bangalore, N., and J. Travis. 1994. Comparison of properties of membrane bound versus soluble forms of human leukocytic elastase and cathepsin G. Biol. Chem. Hoppe-Seyler 375:659.
28. Martodam, R. R., R. J. Baugh, D. Y. Twumasi, and I. E. Liener. 1979. A rapid procedure for the large scale purification of elastase and cathepsin G from human sputum. Prep. Biochem. 9:15.
29. Powers, J. C., and B. F. Gupton. 1977. Reaction of serine proteases with aza-amino acid and aza-peptide derivatives. Methods Enzymol. 46:208.
30. 1-proteinase inhibitor in bronchoalveolar lavage fluids from healthy human smokers and non-smokers. Clin. Chim. Acta 132:309.
31. Boyum, A. 1963. Isolation of mononuclear cells and granulocytes from human blood: isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Invest. 21(Suppl. 97):77.
32. Owen, C. A., M. A. Campbell, S. S. Boukedes, and E. J. Campbell. 1997. Cytokines regulate membrane-bound leukocyte elastase on neutrophils: a novel mechanism for effector activity. Am. J. Physiol. 272:L385.
33. Friedland, J., and E. Silverstein. 1976. A sensitive fluorometric assay for serum angiotensin-converting enzyme. Am. J. Clin. Pathol. 66:416.
34. Voelker, J. R., S. L. Cobb, and R. R. Bowsher. 1994. Improved HPLC-radioimmunoassay for quantifying angiotensin II in plasma. Clin. Chem. 40:1537.
35. Csernok, E., M. Ernst, W. Schmitt, D. F. Bainton, and W. L. Gross. 1994. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin. Exp. Immunol. 95:244.
36. Csemok, E., W. H. Schmitt, M. Ernst, D. F. Bainton, and W. L. Gross. 1993. Membrane surface proteinase 3 expression and intracytoplasmic immunoglobulin on neutrophils from patients with ANCA-associated vasculitides. Adv. Exp. Med. Biol. 336:45.
37. Friedland, J., C. Setton, and E. Silverstein. 1978. Induction of angiotensin converting enzyme in human monocytes in culture. Biochem. Biophys. Res. Commun. 83:843.
38. Caughey, G. H. 1994. Serine proteinases of mast cell and leukocyte granules: a league of their own. Am. J. Respir. Crit. Care Med. 150:S138.
39. Schmolke, R., U. Amon, and H. H. Wolff. 1994. Immunohistochemical studies with skin mast cells. Agents Actions 41:C49.
40. Yoshida, N., M. T. Everitt, H. Neurath, R. G. Woodbury, and J. C. Powers. 1980. Substrate specificity of two chymotrypsin-like proteases from rat mast cells: studies with peptide 4-nitroanalides and comparison with cathepsin G. Biochemistry 19:5799.
41. Travis, J., and G. S. Salvesen. 1983. Human plasma proteinase inhibitors. Annu. Rev. Biochem. 52:655.
42. Das, M., and R. L. Soffer. 1975. Pulmonary angiotensin-converting enzyme: structural and catalytic properties. J. Biol. Chem. 250:6762.
43. Soffer, R. L. 1976. Angiotensin-converting enzyme and the regulation of vaso-active peptides. Annu. Rev. Biochem. 45:73.
44. Urata, H., B. Healy, R. W. Stewart, F. M. Bumpus, and A. Husain. 1990. Angiotensin II-forming pathways in normal and failing human hearts. Circ. Res. 66:883.